These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5805289)

  • 1. The effect of proteolytic enzymes on bovine factor V. I. Kinetics of activation and inactivation by bovine thrombin.
    Colman RW
    Biochemistry; 1969 Apr; 8(4):1438-45. PubMed ID: 5805289
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the stability of bovine plasma factor V.
    Day WC; Barton PG
    Biochim Biophys Acta; 1971 Feb; 261(2):457-68. PubMed ID: 5169152
    [No Abstract]   [Full Text] [Related]  

  • 3. The preparation and properties of factor V from bovine plasma.
    Chulkova T; Hernandez G
    Clin Chim Acta; 1975 Jul; 62(1):21-8. PubMed ID: 1149279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of proteolytic enzymes on bovine factor V. II. Kinetics of activation and inactivation by papain, plasmin, and other proteolytic enzymes.
    Colman RW
    Biochemistry; 1969 Apr; 8(4):1445-50. PubMed ID: 4241000
    [No Abstract]   [Full Text] [Related]  

  • 5. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
    Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
    J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of bovine fibrinogen and thrombin. Early events in the development of clot structure.
    Landis WJ; Waugh DF
    Arch Biochem Biophys; 1975 Jun; 168(2):498-511. PubMed ID: 1169913
    [No Abstract]   [Full Text] [Related]  

  • 8. A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride.
    Lundblad RL
    Biochemistry; 1971 Jun; 10(13):2501-6. PubMed ID: 5105032
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.
    Yang XJ; Blajchman MA; Craven S; Smith LM; Anvari N; Ofosu FA
    Biochem J; 1990 Dec; 272(2):399-406. PubMed ID: 2268268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholate enhancement of interaction between thrombin and tosyl lysine chloromethyl ketone.
    Exner T; Koppel JL
    Biochim Biophys Acta; 1973 Dec; 329(2):233-40. PubMed ID: 4797462
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the esterase (TAMe) and clotting activities of human and bovine thrombin preparations.
    Lanchantin GF; Presant CA; Hart DW; Friedmann JA
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):159-75. PubMed ID: 16955973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Thrombin Inhibitors on Positive Feedback in the Coagulation Cascade.
    Ustinov NB; Zav'yalova EG; Kopylov AM
    Biochemistry (Mosc); 2016 Mar; 81(3):242-8. PubMed ID: 27262193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of the blood-pH and coagulation potential (author's transl)].
    Neef H; Richter M; Fischer U
    Anaesthesist; 1974 Mar; 23(3):158-61. PubMed ID: 4460739
    [No Abstract]   [Full Text] [Related]  

  • 14. Hirudin as a diagnostic agent.
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):36-40. PubMed ID: 2459029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
    Lo CY; Jones C; Glader B; Zehnder JL
    Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure.
    Smith CM; Hanahan DJ
    Biochemistry; 1976 May; 15(9):1830-8. PubMed ID: 1268197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of platelet fibrin-stabilizing factor by thrombin.
    Hung GW; Sonnichsen WJ; James HL; Ganguly P
    Biochim Biophys Acta; 1974 Dec; 371(2):511-8. PubMed ID: 4215455
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of bovine prothrombin activation by an insoluble preparation of bovine factor X a (thrombokinase).
    Stenn KS; Blout ER
    Biochemistry; 1972 Nov; 11(24):4502-15. PubMed ID: 4675875
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of factor V and thrombin inhibitors in children following bovine thrombin exposure during cardiac surgery: a report of three cases.
    Bomgaars L; Carberry K; Fraser C; West A; Teruya J
    Congenit Heart Dis; 2010; 5(3):303-8. PubMed ID: 20576051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine thrombin and activated factor X. Separation and purification.
    Yin ET; Wessler S
    J Biol Chem; 1968 Jan; 243(1):112-7. PubMed ID: 5635939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.